Drugs / 68Ga-R8760
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05999292 | Sep 2023 → May 2024 | adrenal cortex carcinoma | Radionetics Oncology | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-R8760 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05999292 ↗ |